Buspirone Hydrochloride Tablet
Product Images NDC 59651-389

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 59651-389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Patient Instruction Sheet (Buspirone Fig1)

Patient Instruction Sheet (Buspirone Fig1)
Illustration showing identification marks on BUSPIRONE HYDROCHLORIDE tablets by strength. The 30 mg tablet has 'B 30' on the front, with visible divisions for 20 mg (two thirds), 15 mg (half), and 10 mg (one third). The 15 mg tablet has 'B 15' on the front, with divisions for 10 mg (two thirds), 7.5 mg (half), and 5 mg (one third). Empty backsides are shown for both strengths.*
FDA Label Image

Package Label-principal Display Panel (30 mg (30 Tablets Bottle))

Package Label-principal Display Panel (30 mg (30 Tablets Bottle))
Label for BusPIRone Hydrochloride Tablets, USP 30 mg, supplied in a 30-tablet package. The label includes storage instructions, mentions the active ingredient Buspirone hydrochloride USP 30 mg per tablet, and states the product is distributed by Aurobindo Pharma USA, Inc. The label also includes an NDC number and states the tablets are for oral use and prescription only.*
FDA Label Image

Package Label-principal Display Panel (30 mg Blister Carton (10 x 10 Unit-Dose))

Package Label-principal Display Panel (30 mg Blister Carton (10 x 10 Unit-Dose))
Packaging label for Buspirone Hydrochloride Tablets USP 30 mg, oral tablet form. The label indicates a unit-dose pack containing 100 tablets (10 blister cards with 10 tablets each). Manufactured by Aurobindo Pharma Limited and distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions and the NDC 59651-393-78.*
FDA Label Image

Figure (Buspirone Fig2)

Figure (Buspirone Fig2)
An instructional line drawing illustrating how to split a tablet by hand. It shows two hands holding a tablet with the fingers positioned to break it into halves.*
FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))

Package Label-principal Display Panel (5 mg (30 Tablets Bottle))
BusPIRone Hydrochloride Tablets USP 5 mg oral tablet label showing a 30-tablet package. The label includes the NDC 59651-389-30, storage instructions, distributor Aurobindo Pharma USA, Inc. address, and notes the product is made in India by Aurobindo Pharma Limited.*
FDA Label Image

Package Label-principal Display Panel (5 mg Blister Carton (10 x 10 Unit-Dose))

Package Label-principal Display Panel (5 mg Blister Carton (10 x 10 Unit-Dose))
Packaging label for Buspirone Hydrochloride Tablets, USP 5 mg by Aurobindo Pharma Limited. The label shows the product name, strength (5 mg) in an orange oval, and quantity of 100 (10 x 10 unit-dose) tablets. It indicates Rx only, includes storage instructions, and displays the NDC number 59651-389-78 along with the distributor information for Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (7.5 mg (100 Tablets Bottle))

Package Label-principal Display Panel (7.5 mg (100 Tablets Bottle))
Label for Buspirone Hydrochloride Tablets USP 7.5 mg, oral tablets supplied in a 100-tablet container. Distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions and dosage note included. NDC 59651-390-01 is visible on the label.*
FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))

Package Label-principal Display Panel (10 mg (30 Tablets Bottle))
Label for BusPIRone Hydrochloride Tablets, USP 10 mg by Aurobindo Pharma Limited. The label indicates a package of 30 tablets, with each tablet containing 10 mg buspirone hydrochloride. It includes storage instructions, distributor information (Aurobindo Pharma USA, Inc.), and a barcode on the right side.*
FDA Label Image

Package Label-principal Display Panel (10 mg Blister Carton (10 x 10 Unit-Dose))

Package Label-principal Display Panel (10 mg Blister Carton (10 x 10 Unit-Dose))
Buspirone Hydrochloride Tablets USP 10 mg unit-dose packaging label from Aurobindo Pharma Limited. The carton contains 100 tablets in 10 blisters of 10 tablets each. Label includes NDC 59651-391-78, storage instructions, distributor information, and is marked Rx only for oral use.*
FDA Label Image

Package Label-principal Display Panel (15 mg (30 Tablets Bottle))

Package Label-principal Display Panel (15 mg (30 Tablets Bottle))
Label for BusPIRone Hydrochloride Tablets, USP 15 mg, oral tablets. The label states each tablet contains 15 mg of buspirone hydrochloride USP. It is distributed by Aurobindo Pharma USA, Inc., made in India, and comes in a package of 30 tablets. Storage instructions specify 20° to 25°C and protection from temperatures above 30°C.*
FDA Label Image

Package Label-principal Display Panel (15 mg Blister Carton (10 x 10 Unit-Dose))

Package Label-principal Display Panel (15 mg Blister Carton (10 x 10 Unit-Dose))
Packaging label for BusPIRone Hydrochloride Tablets, USP 15 mg oral tablets by Aurobindo Pharma Limited. The carton contains 100 tablets in 10 unit-dose blister cards of 10 tablets each. The label displays dosage strength, quantity, NDC 59651-392-78, and storage information. Distributed by Aurobindo Pharma USA, Inc., made in India.*
FDA Label Image

Chemical Structure (Buspirone Str)

Chemical Structure (Buspirone Str)
Chemical structure of buspirone hydrochloride, showing its distinct molecular components including multiple ring systems and the hydrochloride group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.